Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine

Vaccine

Volumn 27, Issue 23, 2009, Pages 3039-3044

  Galindo, Ruth C ^a   Muñoz, Pilar M ^b   de Miguel, María J ^b   Marin, Clara M ^b   Blasco, José M ^b   Gortazar, Christian ^a   Kocan, Katherine M ^c   de la Fuente, José ^a,c  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b Agrifood Institute of Aragón IA2   (Spain)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Brucella; Genomics; Microarray; Sheep; Vaccine

Indexed keywords

BRUCELLA VACCINE; LIPOCORTIN 1; PROTEIN BAK; TOLL LIKE RECEPTOR 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCELLA OVIS; BRUCELLOSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; GENE EXPRESSION; IMMUNE RESPONSE GENE; IMMUNIZATION; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAM (SHEEP); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; VACCINATION;

ANIMALS; ANNEXIN A1; BACTERIAL VACCINES; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BIOLOGICAL MARKERS; BRUCELLA OVIS; BRUCELLOSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SHEEP; SHEEP DISEASES; TOLL-LIKE RECEPTOR 10; VACCINES, ATTENUATED;

EID: 67349148588     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.046     Document Type: Article

References (40)

1. Blasco J.M. Brucella ovis. In: Nielsen K., and Duncan J.R. (Eds). Animal Brucellosis (1990), CRC Press Inc., Boca Raton, FL 352-378
2. Rajashekara G., Eskra L., Mathison A., Petersen E., Yu Q., Harms J., et al. Brucella: functional genomics and host-pathogen interactions. Anim Health Res Rev 7 (2006) 1-11
3. Cannat A., and Serre A. Genetic factors involved in murine resistance to experimental brucellosis. Dev Biol Stand 56 (1984) 307-313
4. Rezazadeh M., Hajilooi M., Rafiei A., Haidari M., Nikoopour E., Kerammat F., et al. TLR4 polymorphism in Iranian patients with brucellosis. J Infect 53 3 (2006) 206-210
5. Davoudi S., Amirzargar A.A., Hajiabdolbaghi M., Rasoolinejad M., Soodbakhsh A., Jafari S., et al. Th-1 cytokines gene polymorphism in human brucellosis. Int J Immunogenet 33 5 (2006) 355-359
6. Rafiei A., Hajilooi M., Shakib R.J., and Alavi S.A. Transforming growth factor-beta1 polymorphisms in patients with brucellosis: an association between codon 10 and 25 polymorphisms and brucellosis. Clin Microbiol Infect 13 1 (2007) 97-100
7. Budak F., Göral G., Heper Y., Yilmaz E., Aymak F., Baştürk B., et al. IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in Brucellosis. Cytokine 38 1 (2007) 32-36
8. Hashemi S.H., Hajilooi M., Mamani M., and Jamal-Omidi S. Fc gamma receptor IIa polymorphism in patients with brucellosis. Jpn J Infect Dis 60 4 (2007) 196-197
9. Galindo R.C., Muñoz P.M., de Miguel M.J., Marin C.M., Blasco J.M., Gortazar C., et al. Differential expression of inflammatory and immune response genes in rams experimentally infected with a rough virulent strain of Brucella ovis. Vet Immunol Immunopathol 127 (2009) 295-303
10. Cloeckaert A., Jacques I., Grilló M.J., Marín C.M., Grayon M., and Blasco J.M. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. Vaccine 22 (2004) 2827-2835
11. Marín C.M., Jimenez de Bagüés M.P., Barberán M., and Blasco J.M. Comparison of two selective media for the isolation of Brucella melitensis from naturally infected sheep and goats. Vet Rec 138 (1996) 409-411
12. Alton G.G., Jones L.M., Angus R.D., and Verger J.M. Techniques for the brucellosis laboratory (1988), INRA, Paris
13. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
14. Albiger B., Dahlberg S., Henriques-Normark B., and Normark S. Role of the innate immune system in host defence against bacterial infections: focus on the toll-like receptors. J Int Med 261 (2007) 511-528
15. Hasan U., Chaffois C., Gaillard C., Saulnier V., Merck E., Tancredi S., et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 174 5 (2005) 2942-2950
16. Hughes A.L., and Piontkivska H. Functional diversification of the toll-like receptor gene family. Immunogenetics 60 (2008) 249-256
17. Chuang T., and Ulevitch R.J. Identification of hTLR10: a novel human toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 19 1-2 (2001) 157-161
18. Flacher V., Bouschbacher M., Verronèse E., Massacrier C., Sisirak V., Berthier-Vergnes O., et al. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J Immunol 177 11 (2006) 7959-7967
19. Bell M.P., Svingen P.A., Rahman M.K., Xiong Y., and Faubion Jr. W.A. FOXP3 regulates TLR10 expression in human T regulatory cells. J Immunol 179 3 (2007) 1893-1900
20. Nalubamba K.S., Gossner A.G., Dalziel R.G., and Hopkins J. Differential expression of pattern recognition receptors during the development of foetal sheep. Dev Comp Immunol 32 7 (2008) 869-874
21. Bourke E., Bosisio D., Golay J., Polentarutti N., and Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 102 3 (2003) 956-963
22. Ma X., Liu Y., Gowen B.B., Graviss E.A., Clark A.G., and Musser J.M. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE 2 12 (2007) 1318
23. Muñoz P.M., de Miguel M.J., Grilló M.J., Marín C.M., Barberán M., and Blasco J.M. Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams. Vaccine 26 (2008) 2562-2569
24. Bruckheimer E.M., Cho S.H., Sarkiss M., Herrmann J., and McDonnell T.J. The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol 62 (1998) 75-105
25. Wilson C., Foster G.H., and Bitzan M. Silencing of Bak ameliorates apoptosis of human proximal tubular epithelial cells by Escherichia coli-derived Shiga toxin 2. Infection 33 5-6 (2005) 362-367
26. Xiao Y., Zhong Y., Greene W., Dong F., and Zhong G. Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine. Infect Immun 72 9 (2004) 5470-5474
27. Hasan Z., Ashraf M., Tayyebi A., and Hussain R. M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression. BMC Microbiol 18 6 (2006) 78
28. Gross A., Terraza A., Ouahrani-Bettache S., Liautard J.P., and Dornand J. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect Immun 68 1 (2000) 342-351
29. Perretti M., and Solito E. Annexin 1 and neutrophil apoptosis. Biochem Soc Trans 32 3 (2004) 507-510
30. Scannell M., Flanagan M.B., deStefani A., Wynne K.J., Cagney G., Godson C., et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178 7 (2007) 4595-4605
31. Kusumawati A., Cazevieille C., Porte F., Bettache S., Liautard J.P., and Sri Widada J. Early events and implication of F-actin and annexin I associated structures in the phagocytic uptake of Brucella suis by the J-774A.1 murine cell line and human monocytes. Microb Pathog 28 6 (2000) 343-352
32. Eskra L., Mathison A., and Splitter G. Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect Immun 71 (2003) 1125-1133
33. Pei J., and Ficht T.A. Brucella abortus rough mutants are cytopathic for macrophages in culture. Infect Immun 72 (2004) 440-450
34. Pei J., Turse J.E., Wu Q., and Ficht T.A. Brucella abortus rough mutants induce macrophage oncosis that requires bacterial protein synthesis and direct interaction with the macrophage. Infect Immun 74 (2006) 2667-2675
35. Pei J., Wu Q., Kahl-McDonagh M., and Ficht T.A. Cytotoxicity in macrophages infected with rough Brucella mutants is type IV secretion system dependent. Infect Immun 76 (2008) 30-37
36. Refik M., Mehmet N., Durmaz R., and Ersoy Y. Cytokine profile and nitric oxide levels in sera from patients with brucellosis. Braz J Med Biol Res 37 11 (2004) 1659-1663
37. Barrionuevo P., Cassataro J., Delpino M.V., Zwerdling A., Pasquevich K.A., García Samartino C., et al. Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via toll-like receptor 2. Infect Immun 76 1 (2008) 250-262
38. Wyckoff III J.H. Bovine T lymphocyte responses to Brucella abortus. Vet Microbiol 90 (2002) 395-415
39. Jiménez de Bagüés M.P., Terraza A., Gross A., and Dornand J. Different responses of macrophages to smooth and rough Brucella spp: relationship to virulence. Infect Immun 72 (2004) 2429-2433
40. Billard E., Dornand J., and Gross A. Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. Infect Immun 75 (2007) 5916-5923